Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).
Horlocker
Terese T
TT
Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905, USA. horlocker.terese@mayo.edu
Wedel
Denise J
DJ
Benzon
Honorio
H
Brown
David L
DL
Enneking
F Kayser
FK
Heit
John A
JA
Mulroy
Michael F
MF
Rosenquist
Richard W
RW
Rowlingson
John
J
Tryba
Michael
M
Yuan
Chun-Su
CS
D000765:Anesthesia, Conduction; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D017408:Guidelines as Topic; D006408:Hematoma, Subdural / Q000209:etiology; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control / Q000628:therapy
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors